We are continuing to work through the impact from the change healthcare collections disruption along with some delays from a couple of payers updating their systems to reflect higher negotiated rates. These are all timing issues that we are actively working through and we expect DSO to further improve in the Q4. We continue to see improvement in our leverage ratios with both our net and gross leverage ratios improving nearly 50 basis points sequentially to 1.7 and 2.7 times respectively. This represents a significant decline from 4.4 net and 5.3 gross leverage in Q3 of last year. In terms of our outlook for 2024, we are raising our full year revenue range by $17,000,000 at the midpoint to $1,228,000,000 to $1,248,000,000 We are also raising our full year center margin range by $17,000,000 at the midpoint to $382,000,000 to $398,000,000 and the full year adjusted EBITDA range by $15,000,000 at the midpoint to 105 dollars to $115,000,000 For the Q4, we expect revenue of $302,500,000 to $322,500,000 center margin of $89,000,000 to $105,000,000 and adjusted EBITDA of $18,000,000 to $28,000,000 Due to some of the one time rate favorability in the 3rd quarter, we expect modest quarter over quarter decline in total revenue per visit.